Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for Prevention of Cognitive Decline in Breast Cancer Chemotherapy
NCT04033419Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Sep 2019
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of memantine in chemotherapy-induced cognitive impairment (CICI), sponsored by UNC Lineberger Comprehensive Cancer Center. Started Sep 2019; status: completed.
02
Drugs
memantine
03
Conditions
chemotherapy-induced cognitive impairment (CICI)
Beyond the preview
Go deeper on NCT04033419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04033419.